(CIDRAP News) For many years, public health personnel have cited the estimate of 70% to 90% when talking about the level of protection afforded by seasonal influenza vaccines. But last week's meta-analysis of flu vaccine studies in TheLancet Infectious Diseasesalong with several other studies in recent yearshas raised the question of whether it's time to change the message about flu vaccines.
Editors Note: This article covers research conducted in part by CIDRAP researchers. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.
See also: Strict meta-analysis raises questions about flu vaccine efficacy
(CIDRAP News) The Rand Corp. today released its first-ever midseason survey on the uptake of the current influenza vaccine, which found that public officials still have a tall task in front of them to administer this year's record vaccine supply.
The survey indicated that about 30% of US adults had received a flu shot by mid November, but more than half of those surveyed said they didn't plan to get the immunization.
(CIDRAP News) Earlier this year the US Centers for Disease Control and Prevention (CDC) broadened its flu vaccine recommendation to include all school-age children, prompting some health officials to eye school-based immunization programs as an efficient way to improve vaccination rates in young people.
(CIDRAP News) The federal Advisory Committee on Immunization Practices (ACIP) today recommended influenza vaccination for all school-age children, boosting the number of children targeted for flu shots by about 30 million.
The ACIP, whose recommendations are routinely adopted by the Centers for Disease Control and Prevention (CDC), said children from ages 5 through 18 should get flu shots, the CDC announced in a news release.
(CIDRAP News) – As US officials wrap up efforts to gauge the public's response to a draft plan for allocating vaccine supplies during an influenza pandemic, suggestions to fine-tune the plan are emerging, such as giving higher priority to critical infrastructure workers, the families of key healthcare workers, and community pharmacists.